Paula Y Arnold
Overview
Explore the profile of Paula Y Arnold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naik S, Li Y, Talleur A, Selukar S, Ashcraft E, Cheng C, et al.
J Hematol Oncol
. 2024 Jun;
17(1):50.
PMID: 38937803
Background: Relapse remains a challenge after transplantation in pediatric patients with hematological malignancies. Myeloablative regimens used for disease control are associated with acute and long-term adverse effects. We used a...
2.
Sharma A, Triplett B, Chi L, Cross S, Zheng Y, Arnold P
Hum Immunol
. 2024 Jun;
85(4):110829.
PMID: 38824859
A pediatric patient with acute myeloid leukemia was referred to our institution for investigational therapy after disease relapse following a mismatched unrelated donor hematopoietic cell transplant (HCT). Prior to second...
3.
Arnold P
Hum Immunol
. 2022 Mar;
83(10):712-720.
PMID: 35287976
HLA loss in hematologic malignancies is rare at diagnosis but may occur in leukemic cells at disease relapse. Although HLA mismatched hematopoietic cell transplant (HCT) is useful in exploiting graft...
4.
Chou-Wu P, Arnold P
HLA
. 2020 Oct;
96(6):758-759.
PMID: 33073504
Novel allele, DPB1*1049:01, is a one nucleotide variant of DPB1*03:01:01:01.
5.
Lennon G, Bettini M, Burton A, Vincent E, Arnold P, Santamaria P, et al.
Immunity
. 2009 Oct;
31(4):643-53.
PMID: 19818656
Type 1 diabetes is a T cell-mediated autoimmune disease, characterized by lymphocytic infiltration of the pancreatic islets. It is currently thought that islet antigen specificity is not a requirement for...
6.
Burton A, Vincent E, Arnold P, Lennon G, Smeltzer M, Li C, et al.
Diabetes
. 2008 Feb;
57(5):1321-30.
PMID: 18299317
Objective: Type 1 diabetes is mediated by T-cell entry into pancreatic islets and destruction of insulin-producing beta-cells. The relative contribution of T-cells specific for different autoantigens is largely unknown because...
7.
Arnold P, Burton A, Vignali D
J Immunol
. 2004 Aug;
173(5):3103-11.
PMID: 15322170
TCR transgenic mice are valuable tools for dissecting the role of autoantigen-specific T cells in the pathogenesis of type 1 diabetes but are time-consuming to generate and backcross onto congenic...
8.
Arnold P, Vignali K, Miller T, La Gruta N, Cauley L, Haynes L, et al.
J Immunol Methods
. 2002 Nov;
271(1-2):137-51.
PMID: 12445737
MHC tetramers have proven to be powerful reagents for the analysis of MHC class I-restricted T cells. However, generating similarly reliable reagents for MHC class II-restricted T cells has been...
9.
Arnold P, La Gruta N, Miller T, Vignali K, Scott Adams P, Woodland D, et al.
J Immunol
. 2002 Jul;
169(2):739-49.
PMID: 12097376
Peptides bind to MHC class II molecules with a defined periodicity such that the peptide-flanking residues (PFRs) P-1 and P11, which lie outside the core binding sequence (P1-P9), are solvent...